Literature DB >> 10760507

A CDE/CHR-like element mediates repression of transcription of the mouse RB2 (p130) gene.

L Fajas1, L Le Cam, J Polanowska, E Fabbrizio, N Servant, A Philips, G Carnac, C Sardet.   

Abstract

The bipartite repressor elements, termed cell cycle-dependent element (CDE)/cell cycle regulatory element (CCRE)-cell cycle homology region (CHR) control the growth-dependent transcription of the cyclin A, cdc25C, cdc2 genes. Here, we have identified a functional element displaying the signature of the CDE-CHR in the promoter of the mouse RB2 (p130) gene, encoding the retinoblastoma protein family (pRB)-related protein p130. This element locates close to the major transcription start site where it makes major groove contacts with proteins that can be detected in a cellular context using in vivo genomic footprinting techniques. Inactivation of either the CDE or CHR sequence strongly up-regulates the p130 promoter activity in exponentially growing cells, a situation where endogenous p130 gene expression is almost undetectable. Electrophoretic mobility shift assays suggest that two different protein complexes bind independently to the p130 CDE and CHR elements, and that the protein(s) bound to the CDE might be related to those bound on cyclin A and cdc2 promoters.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760507     DOI: 10.1016/s0014-5793(00)01363-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  A single cell cycle genes homology region (CHR) controls cell cycle-dependent transcription of the cdc25C phosphatase gene and is able to cooperate with E2F or Sp1/3 sites.

Authors:  Ulrike Haugwitz; Mark Wasner; Marcus Wiedmann; Katja Spiesbach; Karen Rother; Joachim Mössner; Kurt Engeland
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

Review 2.  Function of the A-type cyclins during gametogenesis and early embryogenesis.

Authors:  Debra J Wolgemuth
Journal:  Results Probl Cell Differ       Date:  2011

3.  Transactivation of murine cyclin A by polyomavirus large and small T antigens.

Authors:  S Schüchner; M Nemethova; A Belisova; B Klucky; W Holnthoner; E Wintersberger
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  E2 Ubiquitin-conjugating Enzyme, UBE2C Gene, Is Reciprocally Regulated by Wild-type and Gain-of-Function Mutant p53.

Authors:  Swati Bajaj; Sk Kayum Alam; Kumar Singha Roy; Arindam Datta; Somsubhra Nath; Susanta Roychoudhury
Journal:  J Biol Chem       Date:  2016-04-28       Impact factor: 5.157

5.  The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2).

Authors:  Donato Tedesco; Jiri Lukas; Steven I Reed
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

6.  The norepinephrine transporter gene is a candidate gene for panic disorder.

Authors:  H N Buttenschøn; A S Kristensen; H N Buch; J H Andersen; J P Bonde; M Grynderup; A M Hansen; H Kolstad; A Kaergaard; L Kaerlev; S Mikkelsen; J F Thomsen; P Koefoed; A Erhardt; D P D Woldbye; A D Børglum; O Mors
Journal:  J Neural Transm (Vienna)       Date:  2011-03-18       Impact factor: 3.575

7.  Regulation of cyclin B2 expression and cell cycle G2/m transition by menin.

Authors:  Ting Wu; Xiuli Zhang; Xiaohua Huang; Yuqing Yang; Xianxin Hua
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

8.  p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner.

Authors:  Alina Molchadsky; Igor Shats; Naomi Goldfinger; Meirav Pevsner-Fischer; Melissa Olson; Ariel Rinon; Eldad Tzahor; Guillermina Lozano; Dov Zipori; Rachel Sarig; Varda Rotter
Journal:  PLoS One       Date:  2008-11-12       Impact factor: 3.240

9.  Transcription of the human cell cycle regulated BUB1B gene requires hStaf/ZNF143.

Authors:  Evelyne Myslinski; Marie-Aline Gérard; Alain Krol; Philippe Carbon
Journal:  Nucleic Acids Res       Date:  2007-05-03       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.